CRIS vs BCRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 29, 2026

CRIS

38.8
AI Score
VS
BCRX Wins

BCRX

55.2
AI Score

Investment Advisor Scores

CRIS

39score
Recommendation
AVOID NEW MONEY

BCRX

55score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CRIS BCRX Winner
Forward P/E 0 14.4928 Tie
PEG Ratio 0 9.3878 Tie
Revenue Growth -66.0% 33.6% BCRX
Earnings Growth 0.0% 1400.0% BCRX
Tradestie Score 38.8/100 55.2/100 BCRX
Profit Margin 0.0% -40.9% CRIS
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD BCRX

Relative Price Performance (Last 90 Days)

CRIS 1M: -41.8% · 3M: -86.5% BCRX 1M: -19.7% · 3M: -19.7%

Current Technical Phase

CRIS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -32.4%), weak momentum, RSI 23

RSI (14): 23.0 · Price: $0.80

BCRX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.4%), weak momentum, RSI 36

RSI (14): 36.0 · Price: $8.17

Fundamentals Snapshot

Metric CRIS BCRX
Market Cap — —
Forward P/E -0.1 8.7
Trailing P/E 0.2 —
Revenue (TTM) — —
Revenue Growth -0.7% 0.3%
Gross Margin -4.9% 0.8%
Operating Margin -8.3% 0.5%
EPS 3.65 -1.40
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BCRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.